Every cosmetic product sold in regulated markets must display an ingredient list that follows a precise, standardized naming convention. This list — known as the INCI list — is one of the most fundamental regulatory requirements in the cosmetics industry. Getting it wrong can delay product launches, trigger regulatory action, or erode consumer trust. Yet for many R&D teams, INCI list generation remains a manual, error-prone process.
What Is INCI?
INCI stands for International Nomenclature of Cosmetic Ingredients. It is the globally recognized naming system that assigns a standardized name to every cosmetic ingredient, regardless of the commercial name a supplier uses or the language spoken in the target market. Developed by the Personal Care Products Council (formerly CTFA) and adopted internationally, INCI names ensure that a consumer — or a regulatory authority — in any country can identify the exact substances present in a cosmetic product.
Within the European Union, INCI listing is mandated by EU Cosmetics Regulation 1223/2009, which requires that ingredient lists appear on product labelling using INCI nomenclature. Other major markets, including the United States, Canada, Japan, ASEAN member states, and Australia, also require or strongly reference INCI-based ingredient declarations, though the specific labelling rules and exceptions vary by jurisdiction.
How an INCI List Is Composed
An INCI list is not simply a list of ingredient names. It follows strict compositional rules that determine the order and presentation of each entry:
- Descending order of concentration: All ingredients present at concentrations above 1% of the total formula must be listed in descending order by weight. The ingredient present in the highest concentration appears first.
- The 1% threshold: Ingredients at or below 1% concentration may be listed in any order after the above-1% ingredients. This flexibility is designed to protect proprietary formulation ratios, but it does not exempt these ingredients from being listed.
- Colorants: Colour Index (CI) numbers are used for colouring agents, and these are listed at the end of the INCI list, regardless of their concentration. Products sold in multiple shades may use the "+/−" (may contain) notation to declare all colorants across the range.
- Multi-component raw materials: When a single raw material supplied to the formulator is itself composed of multiple INCI-named substances (for example, a botanical extract in a carrier solvent with a preservative), each constituent must be declared individually in the INCI list at its effective concentration in the final product.
These rules appear straightforward in isolation. In practice, applying them correctly across a portfolio of dozens or hundreds of formulas — each containing 20 to 60 raw materials, many of which are multi-component — is where complexity escalates rapidly.
Why Manual INCI Generation Fails at Scale
Many cosmetics companies still generate INCI lists using spreadsheets, manual lookups in supplier documentation, and copy-paste workflows. This approach introduces several categories of risk:
- Nomenclature errors: INCI names are precise and often non-intuitive. Confusing "Tocopherol" with "Tocopheryl Acetate," or using an outdated synonym, produces an incorrect ingredient declaration.
- Ordering mistakes: As a formula is modified during development — an emollient adjusted from 1.2% to 0.8%, for instance — the INCI ordering must be recalculated. Manual tracking of which ingredients sit above or below the 1% threshold becomes unreliable across multiple formula versions.
- Missed constituents: Multi-component raw materials are a consistent source of error. If a formulator adds a preservative blend supplied as a single trade-name ingredient but does not decompose it into its INCI constituents, the final list will be incomplete.
- Multi-market divergence: A product destined for both the EU and the US market may require slightly different INCI declarations, because certain naming conventions or regulatory exceptions differ between jurisdictions. Managing these variants manually across a product portfolio invites inconsistency.
How Formulation Software Automates INCI Generation
Purpose-built cosmetics formulation software eliminates these failure modes by generating INCI lists directly from the formulation data itself. In a platform like Labify® Beauté, every raw material in the database is mapped to its INCI constituents, each with its standardized name, CAS number, and function classification. When a formulator builds or modifies a formula, the software already knows the full composition of every ingredient at every concentration.
INCI generation then becomes an automatic calculation, not a manual assembly task. The platform reads the formula, decomposes multi-component raw materials into their individual INCI substances, calculates the effective concentration of each substance in the final product, applies the descending-order rule with the 1% threshold, positions colorants correctly at the end, and outputs a complete, regulation-compliant INCI list.
Version Control and Audit Trail
Because formulation software tracks every version of every formula, the INCI list is regenerated automatically whenever a formula changes. There is no risk of a label carrying an INCI list that corresponds to version 3 of a formula when version 7 is what actually went into production. Every generated list is linked to a specific formula version, creating a complete audit trail for regulatory inspections or internal quality reviews.
Multi-Market Compliance from a Single Source
Advanced formulation platforms maintain jurisdiction-aware INCI databases. The same formula can produce an INCI list formatted for the EU market under Regulation 1223/2009, a separate declaration for the US FDA framework, and another for ASEAN cosmetic regulations — all from a single source of truth. This eliminates the spreadsheet-per-market approach that leads to divergence and regulatory risk when product portfolios grow.
The Broader Impact of Automated INCI
Automating INCI generation is not merely a convenience — it is a structural improvement to how cosmetics companies manage regulatory compliance. It reduces time-to-market by removing a manual bottleneck. It lowers the risk of regulatory rejection due to labelling errors. It frees regulatory affairs teams to focus on substantive compliance questions rather than transcription work. And it provides a foundation for downstream automation: once INCI data flows reliably from formulation, it can feed directly into cosmetic product dossiers, Safety Data Sheets, and consumer-facing labelling systems.
For any cosmetics R&D team managing more than a handful of active formulas, the question is not whether to automate INCI generation, but how much risk they are carrying by not doing so already.